Piroxicam B.P. — CAS 36322-90-4

Piroxicam B.P. is a long-acting non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. It inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes involved in pain and inflammation. It is used for arthritis, musculoskeletal pain, and dysmenorrhea. Mediocon Inc manufactures Piroxicam B.P. API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Treatment of rheumatoid arthritis and osteoarthritis
• Management of ankylosing spondylitis and acute gout
• Relief of primary dysmenorrhea and musculoskeletal pain
• Post-operative and post-traumatic pain management

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: BP / IP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support